Chat with us, powered by LiveChat

Infertility Treatment Devices Market (Type - Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Microscopes, Incubators, and Others; End-user - Fertility Centers, Hospitals & Clinics, Cryobanks, and Research Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Infertility Treatment Devices Market (Type - Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Microscopes, Incubators, and Others; End-user - Fertility Centers, Hospitals & Clinics, Cryobanks, and Research Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Report Code: IGR0134 Category: Healthcare & Medical Devices Published: December, 2023

A recent report published by Infinium Global Research on infertility treatment devices market provides in-depth analysis of segments and sub-segments in the global as well as regional infertility treatment devices market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional infertility treatment devices market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global infertility treatment devices market.

Market Insight:

The global infertility treatment devices market was valued at USD 345 million in 2022 and is expected to reach USD 634.42 million in 2030, with a CAGR of 7.9% during the forecast period 2023-2030.

The incapability to conceive a child through the natural reproduction method called infertility. Patients with infertility issues get a variety of therapies. Treatment for infertility includes medication, surgery, and assisted reproductive technologies. Devices for treating infertility are a growing sector of the healthcare market that deals with the critical issue of reproductive difficulties. These gadgets include a variety of cutting-edge medical tools intended to help single people and couples become pregnant. These consist of instruments used in Assisted Reproductive Technology (ART), such as IVF equipment, ovulation prediction tools, and fertility monitoring. The market for infertility treatment devices is expanding globally as a result of rising infertility rates and rising demand for cutting-edge reproductive treatments. New developments in this area, such as miniaturized, user-friendly devices and telehealth integration are improving patient outcomes and broadening the market. Companies in this industry can take advantage of the chance to solve a critical healthcare need while managing patient confidentiality, clinical effectiveness, and regulatory compliance.

The rise in infertility cases has become a driving force behind the expansion of the infertility treatment devices market. Approximately, 15% of the global population is unable to conceive a child after sex. Unhealthy lifestyle choices, inadequate nutrition, and mounting mental stress are all contributing to the growing prevalence of infertility. There has also been a notable surge in the demand for high-tech medical advancements, such as IVF technology and fertility tracking devices, fueling the industry's growth. Moreover, the ever-evolving healthcare infrastructure worldwide is driving the market forward at an unprecedented pace. This advancement encompasses creating advanced medical centers, incorporating innovative technologies, and increasing accessibility to various healthcare services. Consequently, there is a significant increase in demand for healthcare-related goods and services such as medical equipment, medications, and healthcare technology solutions to keep up with the demands of an ever-changing healthcare landscape. This progressive trend is projected to persist as the healthcare infrastructure continues to evolve and cater to the evolving needs of both patients and healthcare professionals. However, the growth of the market may be hampered due to the high cost of infertility treatment devices and procedures. Moreover, technological advancements in infertility treatment devices create lucrative opportunities for the market.

Infertility Treatment Devices Market Size, Share, Trends | IGR

The infertility treatment devices market is segmented into North America, Asia Pacific, Europe, and ROW. North America is projected to have the largest market share in this area over the forecast period. The sophisticated healthcare system, high rate of infertility cases, constant technological development, favorable regulatory environment, and robust economy are the main causes of this. Together, these factors create a high demand for infertility treatment devices, with North America being the major participant in the industry. Moreover, throughout the projected period, the infertility treatment devices market is expected to develop at the fastest rate in the Asia Pacific. This increase can be attributed to growing disposable incomes, enhanced healthcare facilities, and more knowledge of infertility-related conditions. Demand has also increased as a result of societal and cultural changes that have lessened the stigma attached to obtaining infertility treatments. Furthermore, the region is desirable for infertility treatment devices due to its enormous population base and cost-effective production in nations such as China and India. These factors, together with the growing medical sector, support the market's explosive growth in Asia Pacific.

Report Scope of the Infertility Treatment Devices Market:

Report Coverage Details
Market Size in 2022 USD 345 Million
Market Size by 2030 USD 634.42 Million
Growth Rate from 2023 to 2030 CAGR of 7.9%
Largest Market North America
No. of Pages 180
Market Drivers
  • The surge in infertility cases is a primary catalyst propelling the growth of the infertility treatment devices market.

  • The rapidly developing healthcare infrastructure across the world is propelling the growth of the market.

Market Segmentation By Type, and By End-user
Regional Scope North America, Europe, Asia Pacific, and RoW

Segment Covered

The report on global infertility treatment devices market covers segments such as type, and end-user. On the basis of type, the sub-markets include sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, microscopes, incubators, and others. On the basis of end-user, the sub-markets include fertility centers, hospitals & clinics, cryobanks, and research institutes.

Companies Profiled:

The report provides profiles of the companies in the market such as The Cooper Companies, Inc., Cook Group Incorporated, Esco Micro Pte. Ltd., Hamilton Thorne Inc, IVFtech ApS, Kitazato Corporation, Merck KGaA, Rocket Medical Plc, Vitrolife AB, and Thermo Fisher Scientific Inc.

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the infertility treatment devices market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Frequently Asked Questions (FAQ's)

The global infertility treatment devices market was valued at USD 345 Million in 2022.
It is likely to grow at a CAGR of 7.9% during the forecast period 2023-2030.
The global infertility treatment devices market is estimated to reach USD 634.42 Million by the end of 2030.
North America is anticipated to exhibit high demand for infertility treatment devices market during the forecast period.
The Cooper Companies, Inc., Cook Group Incorporated, Esco Micro Pte. Ltd., Hamilton Thorne Inc, IVFtech ApS, Kitazato Corporation, Merck KGaA, Rocket Medical Plc, Vitrolife AB, and Thermo Fisher Scientific Inc.
CHOOSE LICENCE TYPE

Please Choose One of them.

Google translate
© 2024. Infinium Global Research LLP. All Rights Reserved.